オンコロジーにおける分析ソリューション向けAIの世界市場規模調査＆予測、がんタイプ別、コンポーネント別、地域別分析、2022-2029年

オンコロジーにおける分析ソリューション向けAIの世界市場は、2021年に約4,519億9,000万米ドルと評価され、予測期間2022-2029年に35.50％以上の健全な成長率で成長すると予測されています。

がん診療におけるAIの使用は、がんの検出、がんの診断とスクリーニング、または患者の予後の特徴付けのための医療データの処理、およびケアの提供と臨床業務の最適化のために、主に臨床意思決定サポートを供給することを提供しています。がんの発生率の上昇が業界を牽引しています。これは、世界中で発生件数が急速に増加しているためです。市場theの主な促進要因は、がんの有病率の上昇、遠隔医療と遠隔診療の需要の増加です。さらに、分析ソリューションのためのオンコロジーにおけるAIの進歩、病気診断のためのAIの採用が、予測期間2022年から2029年にかけて、市場に有利な成長機会を生み出しています。

がんは世界的に主要な死因であり、WHOによると、2020年だけでおよそ1,000万人、つまり全死亡者の6分の1近くの死因となっています。WHOは、タバコの使用、アルコール摂取、高い肥満度、運動不足などの要因が、がんを引き起こす可能性があると付け加えています。さらに、肺がんの人は、COVID-19に感染する可能性が高くなります。2018年1月1日から2022年7月2日の間に、疾病管理予防センターの全国人口統計システムで言及された死因の中に、2022年12月に発表された報告書によると、がんがありました。調査したデータによると、週平均で約13,000人のがん関連死が報告されており、2018年と2019年は90％、2020年は88％、2021年は87％のケースでこの病気が主因となっています。しかし、このような困難な状況において、現代のAIやML技術は、患者の診断、ケア、治療を改善する可能性を持っています。パンデミック時のがん画像診断のバックログは人工知能で対応し、医療スタッフの負担を減少させました。しかし、オンコロジーにおける分析ソリューション向けAIの高コストが、2022-2029年の予測期間を通じて市場の成長を阻害しています。

オンコロジーにおける分析ソリューション向けAIの世界市場調査において考慮される主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカを含みます。2021年、北米はシェアで業界をコントロールしました。この拡大は、デジタルインフラの利用可能性や政府の支持的な政策などの要素に起因しています。オンコロジーサービスは、政府の償還額が増加した結果、この地域でより普及すると予想されます。アジア太平洋は、2023年から2030年の間に最も速い増加を遂げると予想されています。インドや日本などの国々における高齢者人口の増加や、病院や診断センターにおけるデジタル技術の利用拡大など、いくつかの要因がこの発展に寄与していると考えられます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国において、業界の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業の競合情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • オンコロジーにおける分析ソリューション向けAI市場、地域別、2019-2029年
  • オンコロジーにおける分析ソリューション向けAI市場、コンポーネント別、2019-2029年
  • オンコロジーにおける分析ソリューション向けAI市場、がんタイプ別、2019年～2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 オンコロジーにおける分析ソリューション向けAIの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 オンコロジーにおける分析ソリューション向けAIの世界市場力学

• オンコロジーにおける分析ソリューション向けAIの市場インパクト分析（2019-2029年）
  • 市場促進要因
    • がんの有病率の増加
    • 遠隔医療・遠隔診療の需要拡大
  • 市場の課題
    • オンコロジーにおける分析ソリューション向けAIの高コスト化
  • 市場機会
    • オンコロジーにおける分析ソリューション向けAIの進展
    • 病気診断のためのAIの導入

第4章 オンコロジーにおける分析ソリューション向けAIの世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 投資採用モデル
• アナリストの提言と結論
• 主な投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 オンコロジーにおける分析ソリューション向けAIの世界市場：コンポーネント別

• マーケットスナップショット
• オンコロジーにおける分析ソリューション向けAIの世界市場：コンポーネント別、実績 - ポテンシャル分析
• オンコロジーにおける分析ソリューション向けAIの世界市場推定・予測（コンポーネント別） 2019-2029
• オンコロジーにおける分析ソリューション向けAI市場、サブセグメント分析
  • データライセンシングサービス
  • ソフトウェアソリューション
  • アナリティクスとその他のサービス

第7章 オンコロジーにおける分析ソリューション向けAIの世界市場：がんタイプ別

• マーケットスナップショット
• オンコロジーにおける分析ソリューション向けAIの世界市場：がんタイプ別、実績 - ポテンシャル分析
• オンコロジーにおける分析ソリューション向けAIの世界市場、がんタイプ別推定・予測2019-2029
• オンコロジーにおける分析ソリューション向けAI市場、サブセグメント分析
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 大腸がん
  • 脳腫瘍
  • 腎臓がん
  • 非ホジキンリンパ腫
  • 膀胱がん

第8章 オンコロジーにおける分析ソリューション向けAIの世界市場：地域別分析

• オンコロジーにおける分析ソリューション向けAI市場、地域別市場スナップショット
• 北米
  • 米国
    • コンポーネント別の推定・予測、2019年～2029年
    • がんタイプ別の推定・予測、2019年～2029年
  • カナダ
• 欧州オンコロジーにおける分析ソリューション向けAI市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のオンコロジーにおける分析ソリューション向けAI市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのオンコロジーにおける分析ソリューション向けAI市場スナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Azra AI
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • International Business Machines Corporation
  • Siemens Healthineers
  • Intel Corporation
  • GE Healthcare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • Concert.AI
  • Median Technologies
  • Path AI

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global AI In Oncology for Analytical Solutions Market, report scope
• TABLE 2. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Component 2019-2029 (USD Billion)
• TABLE 4. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
• TABLE 5. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global AI In Oncology for Analytical Solutions Market
• TABLE 70. List of primary sources, used in the study of global AI In Oncology for Analytical Solutions Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global AI In Oncology for Analytical Solutions Market, research methodology
• FIG 2. Global AI In Oncology for Analytical Solutions Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global AI In Oncology for Analytical Solutions Market, key trends 2021
• FIG 5. Global AI In Oncology for Analytical Solutions Market, growth prospects 2022-2029
• FIG 6. Global AI In Oncology for Analytical Solutions Market, porters 5 force model
• FIG 7. Global AI In Oncology for Analytical Solutions Market, pest analysis
• FIG 8. Global AI In Oncology for Analytical Solutions Market, value chain analysis
• FIG 9. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global AI In Oncology for Analytical Solutions Market, regional snapshot 2019 & 2029
• FIG 15. North America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 16. Europe AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 19. Global AI In Oncology for Analytical Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global AI In Oncology for Analytical Solutions Market is valued at approximately USD 451.99 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 35.50% over the forecast period 2022-2029. The use of AI in cancer practice offers to supply clinical decision support majorly for processing medical data for cancer detection, cancer diagnosis and screening, or characterization of patient prognosis, and optimizing care delivery and clinical operations. The rising incidence of cancer is driving the industry. This is because the number of instances around the world is increasing quickly. The major driving factor for the market the is rising prevalence of cancer, the growing demand for telemedicine and remote care. Moreover, advancements in AI in oncology for analytical solutions, the adoption of AI for disease diagnosis is creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Cancer is a major cause of death worldwide, and according to the WHO, it was responsible for roughly 10 million deaths in 2020 alone, or nearly one-sixth of all deaths. The World Health Organization added that factors like tobacco use, alcohol consumption, a high body mass index, and a lack of physical exercise can cause cancer. Furthermore, individuals with lung cancer have a higher chance of contracting COVID-19. Among the causes of death mentioned in the National Vital Statistics System of the Centers for Disease Control and Prevention between January 1, 2018, and July 2, 2022, was cancer, according to a report released in December 2022. According to the data examined, there were approximately 13,000 cancer-related deaths reported weekly on average, with this illness being the primary cause in 90% of cases in 2018 and 2019, 88% of cases in 2020, and 87% of cases in 2021. However, in these difficult situations, contemporary AI and ML technologies have the potential to improve patient diagnosis, care, and treatment. The backlog of cancer imaging during the pandemic was addressed with artificial intelligence, which decreased the burden on the medical staff. However, the high cost of AI In Oncology For Analytical Solutions stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global AI In Oncology for Analytical Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America controlled the industry with a share. The expansion is ascribed to elements such as the availability of digital infrastructure and supportive governmental policies. Oncology services are anticipated to become more popular in the area as a result of increased government reimbursements. Asia Pacific is anticipated to experience the fastest increase between 2023 and 2030. Several factors, including the rising elderly population in nations such as India and Japan and the expanding use of digital technologies in hospitals and diagnostic centers, can be credited for this development.

Major market player included in this report are:

• Azra AI
• International Business Machines Corporation
• Siemens Healthineers
• Intel Corporation
• GE Healthcare
• NVIDIA Corporation
• Digital Diagnostics Inc.
• Concert.AI
• Median Technologies
• Path AI

Recent Developments in the Market:

• A group of scientists from the National Institutes of Health and Global Good created a machine learning algorithm that can analyze digital pictures of the cervix in women in 2019.
• The GI GeniusTM intelligent endoscopy module, which is driven by AI and aids healthcare professionals in the detection of colorectal cancer by improving visualization during colonoscopy, was introduced by Medtronic plc in August 2022 in India.

Global AI In Oncology for Analytical Solutions Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Component, Cancer Type, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Component:

• Data Licensing Services
• Software Solutions
• Analytics and Other Services

By Cancer Type:

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Kidney Cancer
• Non-Hodgkin Lymphoma
• Bladder Cancer

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. AI In Oncology for Analytical Solutions Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. AI In Oncology for Analytical Solutions Market, by Component, 2019-2029 (USD Billion)
  • 1.2.3. AI In Oncology for Analytical Solutions Market, by Cancer Type, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global AI In Oncology for Analytical Solutions Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global AI In Oncology for Analytical Solutions Market Dynamics

• 3.1. AI In Oncology for Analytical Solutions Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of cancer
    • 3.1.1.2. Growing demand for telemedicine and remote care
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of AI In Oncology for Analytical Solutions
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in AI in oncology for analytical solutions
    • 3.1.3.2. Adoption of AI for disease diagnosis

Chapter 4. Global AI In Oncology for Analytical Solutions Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global AI In Oncology for Analytical Solutions Market, by Component

• 6.1. Market Snapshot
• 6.2. Global AI In Oncology for Analytical Solutions Market by Component, Performance - Potential Analysis
• 6.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Component 2019-2029 (USD Billion)
• 6.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
  • 6.4.1. Data Licensing Services
  • 6.4.2. Software Solutions
  • 6.4.3. Analytics and Other Services

Chapter 7. Global AI In Oncology for Analytical Solutions Market, by Cancer Type

• 7.1. Market Snapshot
• 7.2. Global AI In Oncology for Analytical Solutions Market by Cancer Type, Performance - Potential Analysis
• 7.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
• 7.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
  • 7.4.1. Breast Cancer
  • 7.4.2. Lung Cancer
  • 7.4.3. Prostate Cancer
  • 7.4.4. Colorectal Cancer
  • 7.4.5. Brain Tumor
  • 7.4.6. Kidney Cancer
  • 7.4.7. Non-Hodgkin Lymphoma
  • 7.4.8. Bladder Cancer

Chapter 8. Global AI In Oncology for Analytical Solutions Market, Regional Analysis

• 8.1. AI In Oncology for Analytical Solutions Market, Regional Market Snapshot
• 8.2. North America AI In Oncology for Analytical Solutions Market
  • 8.2.1. U.S. AI In Oncology for Analytical Solutions Market
    • 8.2.1.1. Component breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Cancer Type breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada AI In Oncology for Analytical Solutions Market
• 8.3. Europe AI In Oncology for Analytical Solutions Market Snapshot
  • 8.3.1. U.K. AI In Oncology for Analytical Solutions Market
  • 8.3.2. Germany AI In Oncology for Analytical Solutions Market
  • 8.3.3. France AI In Oncology for Analytical Solutions Market
  • 8.3.4. Spain AI In Oncology for Analytical Solutions Market
  • 8.3.5. Italy AI In Oncology for Analytical Solutions Market
  • 8.3.6. Rest of Europe AI In Oncology for Analytical Solutions Market
• 8.4. Asia-Pacific AI In Oncology for Analytical Solutions Market Snapshot
  • 8.4.1. China AI In Oncology for Analytical Solutions Market
  • 8.4.2. India AI In Oncology for Analytical Solutions Market
  • 8.4.3. Japan AI In Oncology for Analytical Solutions Market
  • 8.4.4. Australia AI In Oncology for Analytical Solutions Market
  • 8.4.5. South Korea AI In Oncology for Analytical Solutions Market
  • 8.4.6. Rest of Asia Pacific AI In Oncology for Analytical Solutions Market
• 8.5. Latin America AI In Oncology for Analytical Solutions Market Snapshot
  • 8.5.1. Brazil AI In Oncology for Analytical Solutions Market
  • 8.5.2. Mexico AI In Oncology for Analytical Solutions Market
• 8.6. Rest of The World AI In Oncology for Analytical Solutions Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Azra AI
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. International Business Machines Corporation
  • 9.2.3. Siemens Healthineers
  • 9.2.4. Intel Corporation
  • 9.2.5. GE Healthcare
  • 9.2.6. NVIDIA Corporation
  • 9.2.7. Digital Diagnostics Inc.
  • 9.2.8. Concert.AI
  • 9.2.9. Median Technologies
  • 9.2.10. Path AI

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption